Moreover, RGO was functionalized with polycationic poly-L-lysine (PLL) to increase its drug loading capability with colloidal stability, as shown in Figure 4B. Further, RGO-PLL was labelled with anti-HER2 to form a bond with HER2 receptors to detect breast cancer cells [77]. The gene discussed is ERBB2; the disease is breast cancer.